FIGURE 5.

Gefitinib response in Asian and non‐Asian patients with non‐small cell lung cancer ¹⁰³ and the prevalence of somatic EGFR mutations ¹⁰⁴ associated with tyrosine kinase responses. ¹⁰⁵ (Figure reproduced with permission from Chang et al., 2006) ¹⁰³